RESULTS
Of the 31 recruited patients, 21 had Oura data available from the pretreatment period of more than 1 night. Of these 21 patients, 17 patients had a complete data set with pre‐ and posttreatment Oura‐data and ISI questionnaires. The reported baseline values included all 21 patients, and the analysis of treatment effects included 17 patients (10 in rTMS group and 7 in sham group).